Canadian Blood Services, Centre for Blood Research and the Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Vox Sang. 2011 Jan;100(1):84-91. doi: 10.1111/j.1423-0410.2010.01433.x.
The application of proteomic technologies to transfusion medicine has opened new avenues to our understanding of the products we prepare for patients and the processes that impact the quality of those products. The development of the field of proteomics has paralleled that of transfusion medicine with over a century of key scientific accomplishments required to bring us to our modern systems. We review the technology of proteomics and its application to transfusion medicine with specific reference to the analysis of blood products, both fractionated and fresh. Although the use of proteomic tools to address transfusion medicine questions is really just beginning, it is clear that this method of analysis provides different insights into unaddressed issues in the area of blood product research. Proteomics also offers the promise of improving our approach to the control of blood product quality and even the assessment of blood donors, but these are efforts for the near future.
蛋白质组学技术在输血医学中的应用为我们理解为患者准备的产品以及影响这些产品质量的过程开辟了新途径。蛋白质组学领域的发展与输血医学平行发展,需要一个多世纪的关键科学成就才能使我们达到现代系统。我们回顾了蛋白质组学技术及其在输血医学中的应用,特别提到了血液制品的分析,包括分离和新鲜制品。尽管使用蛋白质组学工具来解决输血医学问题才刚刚开始,但很明显,这种分析方法为血液制品研究领域中未解决的问题提供了不同的见解。蛋白质组学还为改进我们控制血液产品质量甚至评估献血者的方法提供了希望,但这些都是未来的努力方向。